Oxygenta Pharmaceutical (BOM:524636) Debt-to-Equity : -2.84 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Debt-to-Equity?

Oxygenta Pharmaceutical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹82.3 Mil. Oxygenta Pharmaceutical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹490.0 Mil. Oxygenta Pharmaceutical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹-201.2 Mil. Oxygenta Pharmaceutical's debt to equity for the quarter that ended in Mar. 2024 was -2.84.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Oxygenta Pharmaceutical's Debt-to-Equity or its related term are showing as below:

BOM:524636' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.84 Med: -0.87 Max: -0.6
Current: -2.84

During the past 13 years, the highest Debt-to-Equity Ratio of Oxygenta Pharmaceutical was -0.60. The lowest was -2.84. And the median was -0.87.

BOM:524636's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.3 vs BOM:524636: -2.84

Oxygenta Pharmaceutical Debt-to-Equity Historical Data

The historical data trend for Oxygenta Pharmaceutical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Debt-to-Equity Chart

Oxygenta Pharmaceutical Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

-0.66

-1.26

-1.51

-1.47

-2.84

Oxygenta Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-1.47	N/A	-2.23	N/A	-2.84

Competitive Comparison of Oxygenta Pharmaceutical's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxygenta Pharmaceutical's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's Debt-to-Equity falls into.

Oxygenta Pharmaceutical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Oxygenta Pharmaceutical's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(82.32	+	490.017)	/	-201.224
	=	-2.84

Oxygenta Pharmaceutical's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(82.32	+	490.017)	/	-201.224
	=	-2.84

Oxygenta Pharmaceutical (BOM:524636) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Oxygenta Pharmaceutical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032

Website

http://oxygentapharma.com

Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines